Quality prescribing strategy for respiratory: a guide for improvement
| A&A | Ayrshire and Arran |
| ACQ (6) | Asthma Control Questionnaire |
| ACP | Activated Clotting Time |
| ACT | Asthma Control Test |
| AF | Atrial Fibrillation |
| AHP | Allied Healthcare Professional |
| ANA | Anti-Nuclear Antibodies |
| ANCA | Anti-Neutrophil Cytoplasm Antibodies |
| ANP | Advanced Nurse Practitioner |
| ARDs | Acute Respiratory Distress Syndrome |
| BMI | Body Mass Index |
| BNF | British National Formulary |
| BTS | British Thoracic Society |
| CAT | Computerized Axial Tomography |
| CF | Cystic Fibrosis |
| CO2 | Carbon dioxide |
| COPD | Chronic Obstructive Pulmonary Disease |
| CRP | C-reactive protein |
| CSH | Centre for Sustainable Health |
| CXR | Chest X-ray |
| DEXA | Dual Energy X-ray Absorptiometry |
| DPI | Dry Powder Inhaler |
| DTaP | Diptheria-Tetanus-Pertussis Vaccine |
| ECG | Electrocardiogram |
| ERS | European Respiratory Society |
| EU | European Union |
| FBC | Full blood count |
| FeNO | Fractionated Exhaled Nitric oxide |
| FEV1 | Forced Expiratory Volume in 1 Second |
| FV | Forth Valley |
| FVC | Forced Vital Capacity |
| GGC | Greater Glasgow and Clyde |
| GOLD | Global Initiative for Chronic Obstructive Lung Disease |
| GP | General Practitioner |
| GWI | Global Water Intelligence |
| GWP | Global Warming Potential |
| HFA | Hydrofluoroalkane |
| HIS | Healthcare Improvement Scotland |
| HSCP | Health and Social Care Partnership |
| ICS | Inhaled Corticosteroids |
| ILD | Interstitial Lung Disease |
| IPF | Idiopathic pulmonary fibrosis |
| IT | Information Technology |
| ITU | Intensive Therapy Unit |
| ISD | Information Services Division |
| LABA | Long-Acting Beta Agonist |
| LAMA | Long-Acting Muscarinic Antagonist |
| LRA | Leukotriene receptor antagonists |
| MAB | Monoclonal antibody |
| MART | Maintenance and Reliever Therapy |
| MCN | Managed Clinical Network |
| MCR | Medicines Care and Review |
| MDI/pMDI | Metered-Dose Inhaler (pressurised) |
| MRC | Medical Research Council - breathlessness scale |
| NCDs | Non-communicable Diseases |
| NHS | National Health Service |
| NICE | National Institute for Health and Social Care Excellence |
| NRAD | National Review of Asthma Deaths |
| NTM | Nontuberculous Mycobacterial |
| OCS | Oral corticosteroids |
| PFTs | Pulmonary Function Tests |
| PIS | Prescribing Information System |
| PRISMS | Prescribing Information System for Scotland |
| QI | Quality Improvement |
| RAST | RadioAllergosorbent Test |
| RCGP | Royal College of General Practitioners |
| SABA | Short Acting Beta Agonists |
| SAMA | Short-Acting Muscarinic Antagonist |
| SAPG | Scottish Antimicrobial Prescribing group |
| Sats | Saturations (Oxygen) |
| SIGN BTS | Scottish Intercollegiate Guidelines Network/British Thoracic Society |
| SMC | Scottish Medicines Consortium |
| SPC | Summary of Product Characteristics |
| STU | Scottish Therapeutics Utility |
| TFT | Thyroid Function Test |
| U and Es | Urea and Electrolytes |
| VBA | Very Brief Advice |
| WHO | World Health Organisation |